Emerging Research & Living With AMD

Research into age-related macular degeneration (AMD) is moving beyond slowing vision loss toward the possibility of protecting, replacing, or restoring damaged retinal cells.

At the same time, improvements in technology are helping people with impaired vision continue reading, communicating, and living independently.

The encouraging news is that progress is occurring both in medical treatments and in practical ways to live well with AMD.

Gene Therapy

Gene therapy aims to introduce genetic instructions into retinal cells to change how they function.

Researchers are investigating whether a single treatment might help control abnormal blood vessel growth in wet AMD, potentially reducing the need for frequent injections.

Other experimental approaches seek to protect retinal cells or make surviving cells respond to light.

In 2026, researchers reported preliminary results from an experimental gene therapy designed to help surviving retinal cells act as light sensors. Further trials are planned to investigate its potential for advanced dry AMD.

These approaches are promising, but gene therapies for AMD remain experimental.

Stem Cells and Retinal Repair

In advanced AMD, some of the cells supporting the retina become damaged or die.

Researchers are investigating whether stem cells can be used to replace damaged retinal pigment epithelial cells, which help maintain the health of the retina.

Early clinical studies are examining the safety and feasibility of transplanting these cells.

The long-term goal is to preserve retinal function and possibly restore some vision.

However, important questions remain about safety, durability, and whether transplanted cells can meaningfully improve eyesight.

Stem cell treatments are not yet established therapies for AMD. Patients should be cautious about clinics offering unproven treatments outside properly regulated clinical trials.

Better Monitoring at Home

Early detection of changes in vision can make an important difference, especially when dry AMD develops into wet AMD.

The traditional Amsler grid is a simple pattern of straight lines used to detect distortion or missing areas in central vision.

Newer technologies can provide more sophisticated monitoring.

Some home devices detect subtle visual changes, while newer home optical coherence tomography (OCT) systems can measure retinal changes in selected patients with wet AMD.

These technologies may help ophthalmologists recognize disease activity and adjust treatment schedules.

However, they do not replace regular examinations or the need to report sudden visual changes promptly.

Living With Reduced Vision

AMD primarily affects central vision. Many people retain peripheral vision, allowing them to move around and remain independent.

Practical changes can make everyday activities easier:

Many of these technologies are becoming easier to use and more affordable.

Low-Vision Rehabilitation

People sometimes assume that little can be done once vision has been permanently lost.

But low-vision rehabilitation can help people make better use of their remaining eyesight.

Specialists can recommend magnifying devices, teach alternative reading techniques, and help people adapt everyday activities.

Training may also help individuals use their peripheral vision more effectively.

An ophthalmologist can provide a referral to a low-vision rehabilitation specialist.

Maintaining Independence

Vision loss can affect more than reading and driving. It may influence confidence, social activities, and willingness to leave home.

Family support, accessible technology, and rehabilitation services can make a meaningful difference.

For older adults, maintaining independence may involve adapting familiar activities rather than giving them up.

Even when vision cannot be fully restored, there are often ways to preserve quality of life and continue doing enjoyable activities.

Bottom Line

Macular degeneration research is advancing in several directions.

Gene therapy, stem cell treatments, and retinal repair may eventually provide options beyond today's medications, although these approaches remain experimental.

Meanwhile, low-vision rehabilitation, electronic magnification, and accessible technology can already improve daily life.

The goal is not only to preserve eyesight, but also to help people maintain independence and enjoy life despite changes in vision.

Learn More

A Gene Therapy Aims to Restore Sight

American Academy of Ophthalmology: Discusses experimental gene therapy and early research presented in 2026.

At-Home Monitoring for AMD

American Academy of Ophthalmology: Explains newer home-monitoring technologies and their potential benefits.

Low Vision

National Eye Institute: Practical information about assistive devices, rehabilitation, and maintaining independence.